George Sing
Director/Board Member chez REGENERON PHARMACEUTICALS, INC.
Fortune : 27 M $ au 31/03/2024
Profil
George L.
Sing was the founder of Merrill Lynch Ventures LLC, Noveome Biotherapeutics, Inc., ATV Capital Management Inc., Merrill Lynch Venture Capital, Inc., and Lancet Capital Partners LLC.
He is currently the Chief Executive Officer at GanD, Inc. since 2016, Chairman at Grace Science LLC since 2017, and an Independent Director at Regeneron Pharmaceuticals, Inc. since 1988.
His former position includes being a Director at VivoQuest, Inc. He holds an MBA from Harvard Business School and an undergraduate degree from Stevens Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/02/2024 | 28 499 ( 0,03% ) | 27 M $ | 31/03/2024 |
Postes actifs de George Sing
| Sociétés | Poste | Début |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Director/Board Member | 08/01/1988 |
Lancet Capital Partners LLC
 Lancet Capital Partners LLC Investment ManagersFinance Lancet Capital Partners LLC (Lancet Capital Partners) is a venture capital firm founded in 1998 by William J. Golden and George L. Sing. The firm is headquartered in Pittsburgh, Pennsylvania. | Founder | - |
| GanD, Inc. | Chief Executive Officer | 01/01/2016 |
| Grace Science LLC | Chairman | 01/01/2017 |
Anciens postes connus de George Sing
| Sociétés | Poste | Fin |
|---|---|---|
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Founder | - |
| Merrill Lynch Venture Capital, Inc. | Founder | - |
VivoQuest, Inc.
 VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Director/Board Member | - |
Merrill Lynch Ventures LLC
 Merrill Lynch Ventures LLC Investment ManagersFinance Merrill Lynch Ventures LLC is a venture capital firm headquartered in New York City. The firm is a division of the Merrill Lynch Global Markets & Investment Banking Group and their ultimate parent is Bank of America Corp. (NYSE: BAC). | Founder | - |
ATV Capital Management Inc.
 ATV Capital Management Inc. Investment ManagersFinance ATV Capital Management Inc. (ATV Capital Management) is a venture capital firm founded in 1979. The firm is headquartered in Boston, Massachusetts. | Founder | - |
Formation de George Sing
| Stevens Institute of Technology | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Merrill Lynch Ventures LLC
Merrill Lynch Ventures LLC Investment ManagersFinance Merrill Lynch Ventures LLC is a venture capital firm headquartered in New York City. The firm is a division of the Merrill Lynch Global Markets & Investment Banking Group and their ultimate parent is Bank of America Corp. (NYSE: BAC). | Finance |
ATV Capital Management Inc.
ATV Capital Management Inc. Investment ManagersFinance ATV Capital Management Inc. (ATV Capital Management) is a venture capital firm founded in 1979. The firm is headquartered in Boston, Massachusetts. | Finance |
VivoQuest, Inc.
VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Health Technology |
| Merrill Lynch Venture Capital, Inc. | |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Health Technology |
Lancet Capital Partners LLC
Lancet Capital Partners LLC Investment ManagersFinance Lancet Capital Partners LLC (Lancet Capital Partners) is a venture capital firm founded in 1998 by William J. Golden and George L. Sing. The firm is headquartered in Pittsburgh, Pennsylvania. | Finance |
| Grace Science LLC | |
| GanD, Inc. |
